A new study shows how the single-molecule organization of receptors in a cellular context determines the function of antibodies, opening up new pathways for the development of cancer immunotherapies.

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causes mild to severe infection in humans, and to date, it has claimed more than 4.77 million lives across the world. This virus is ...

SARS-CoV-2, the virus that causes COVID-19, has mutated many times into new variants, some that we don't hear about because they haven't changed the course of the pandemic, while others have become ...

A new study points to the need for better antibody validation, and outlines a process that other labs can use to make sure the antibodies they work with function properly. A new study points to the ...

Real-world evidence highlights the effectiveness of teclistamab and elranatamab in treating frail multiple myeloma patients, paving the way for future therapies.

Coronavirus disease 2019 (COVID-19) has had devastating worldwide effects on public health and economies. While global vaccination schemes are beginning to control the spread of the disease, there are ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...